JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 2, February 1994 TABLE OF CONTENTS
  Archives
 • Online Features
  Clinical Reviews
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Cefuroxime Axetil in the Treatment of Sinusitis

A Review

Gary E. Paker, PharmD; James A. Graham, PharmD; Alan M. Rauch, MD; Jeffrey J. Collins, PhD

Arch Fam Med. 1994;3(2):165-175.


Abstract



Cefuroxime axetil is a β-lactamase—stable, second-generation, oral cephalosporin that penetrates sinus tissue in concentrations exceeding the MIC90 values (the minimum concentration of drug needed to inhibit the growth of 90% of an isolate of a particular microorganism) for pathogens most commonly associated with acute sinusitis, including Streptococcus pneumoniae and Haemophilus influenzae. A review of all clinical data published to date demonstrates that cefuroxime axetil has been evaluated in the treatment of acute sinusitis and acute exacerbations of chronic sinusitis ("acute-on-chronic sinusitis") in 18 clinical trials involving 1516 assessable patients. In 12 randomized, comparative trials, the rates of satisfactory clinical outcomes (cure or improvement, 79% to 100%) and bacteriologic eradication (84% to 100%) reported with the use of 250 mg of cefuroxime axetil twice daily were similar to those observed with the use of amoxicillin, amoxicillin/clavulanate potassium, cefaclor, cefadroxil, cefixime, clarithromycin, and doxycycline. In these comparisons, no antibiotic demonstrated any therapeutic advantages over cefuroxime axetil regarding time to symptom abatement. Cefuroxime axetil was at least as well tolerated as the other antibiotics. Overall, the role of cefuroxime axetil in the treatment of sinusitis appears to be as one of the broad-spectrum antibiotics that can be used for infections due to the most commonly implicated sinus pathogens, especially those due to the increasing number of relatively penicillin-resistant strains of S pneumoniae and β-lactamase— producing strains of H influenzae and Moraxella catarrhalis.



Author Affiliations



From Glaxo Inc, Glaxo Inc Research Institute, Research Triangle Park, NC.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fluoroquinolones compared with {beta}-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials
Karageorgopoulos et al.
CMAJ 2008;178:845-854.
ABSTRACT | FULL TEXT  

Comparison of Cefuroxime With or Without Intranasal Fluticasone for the Treatment of Rhinosinusitis: The CAFFS Trial: A Randomized Controlled Trial
Dolor et al.
JAMA 2001;286:3097-3105.
ABSTRACT | FULL TEXT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.

DCSIMG